<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33009425</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.</ArticleTitle><Pagination><StartPage>16378</StartPage><MedlinePgn>16378</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">16378</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-71849-3</ELocationID><Abstract><AbstractText>Dengue virus (DENV) is a mosquito-borne pathogen that is becoming a serious global threat, owing to its rising incidence in inter-tropical regions that yield over 50 million annual infections. There are currently no approved antiviral agents for the management of dengue, and recent shortcomings in its immunization called for immediate action to develop effective drugs with prophylactic ability to better manage its infection. In an attempt to discover novel antiviral sources, we identified the medicinal herb Polygonum cuspidatum (PC) as a bioactive botanical material against DENV infectivity. Specifically, the methanolic extract from PC rhizomes (PCME) potently inhibited DENV infection without causing significant cytotoxicity. Further examination on the viral life cycle demonstrated that PCME particularly targeted the initial stages of DENV infection, while pre- and post-infection treatments had no effect. More importantly, the PCME could efficiently inactivate DENV free virus particles and block the viral attachment and entry/fusion events without apparently influencing viral replication, egress, and cell-to-cell spread. The antiviral effect of PCME was also recapitulated in infection analysis using DENV pseudoparticles displaying viral structural proteins that mediate DENV particle entry. Besides, PCME treatment also inhibited direct DENV entry into several cell types relevant to its infection and reduced viral infectivity of other members of the Flaviviridae family, including the hepatitis C virus (HCV) and Zika virus (ZIKV). Due to its potency against DENV entry, we suggest that the phytobioactive extract from PC is an excellent starting point as an antiviral source material for further development of therapeutic strategies in the prophylactic management of DENV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kuo</LastName><ForeName>Yu-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Chi Mei Medical Center, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Ching-Hsuan</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin-Wei</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chien-Ju</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jassey</LastName><ForeName>Alagie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huey-Nan</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey Chuen</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology &amp; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Diseases and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Ming-Hong</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Liang-Tzung</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. ltlin@tmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. ltlin@tmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NHC-142832</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045468" MajorTopicYN="N">Fallopia japonica</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016174" MajorTopicYN="N">Hepacivirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064209" MajorTopicYN="N">Phytochemicals</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010946" MajorTopicYN="N">Plants, Medicinal</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33009425</ArticleId><ArticleId IdType="pmc">PMC7532532</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-71849-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-71849-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzman MG, et al. Dengue: a continuing global threat. Nat. Rev. Microbiol. 2010;8:S7&#x2013;S16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 2005;3:13. doi: 10.1038/nrmicro1067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1067</ArticleId><ArticleId IdType="pubmed">15608696</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in Southeast Asia. PLoS Negl. Trop. Dis. 2013;7:e2055. doi: 10.1371/journal.pntd.0002055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002055</ArticleId><ArticleId IdType="pmc">PMC3578748</ArticleId><ArticleId IdType="pubmed">23437406</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). Dengue control, https://www.who.int/denguecontrol/en/ (2018).</Citation></Reference><Reference><Citation>Paessler S, Walker DH. Pathogenesis of the viral hemorrhagic fevers. Annual review of pathology. 2013;8:411&#x2013;440. doi: 10.1146/annurev-pathol-020712-164041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-020712-164041</ArticleId><ArticleId IdType="pubmed">23121052</ArticleId></ArticleIdList></Reference><Reference><Citation>Torresi J, Ebert G, Pellegrini MJH. Vaccines licensed and in clinical trials for the prevention of dengue. Hum. Vaccine Immunother. 2017;13:1059&#x2013;1072. doi: 10.1080/21645515.2016.1261770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2016.1261770</ArticleId><ArticleId IdType="pmc">PMC5443395</ArticleId><ArticleId IdType="pubmed">28281864</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer O. Philippines halts dengue immunisation campaign owing to safety risk. BMJ. 2017;359:j5759. doi: 10.1136/bmj.j5759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j5759</ArticleId><ArticleId IdType="pubmed">29233814</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Qin R, Li X, Zhou H. Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb et. Zucc.: a review. J. Ethnopharmacol. 2013;148:729&#x2013;745. doi: 10.1016/j.jep.2013.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2013.05.007</ArticleId><ArticleId IdType="pubmed">23707210</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Li C, Kwok ST, Zhang QW, Chan SW. A review of the pharmacological effects of the dried root of Polygonum cuspidatum (Hu Zhang) and its constituents. Evid. Based Complement Alternat. Med. 2013;2013:208349. doi: 10.1155/2013/208349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/208349</ArticleId><ArticleId IdType="pmc">PMC3806114</ArticleId><ArticleId IdType="pubmed">24194779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Huang T, Guo S, Wang R. Effects of emodin extracted from Rhizoma Polygoni Cuspidati in treating HSV-1 cutaneous infection in guinea pigs. J. Anhui Tradit. Chin. Med. Coll. 2003;22:36&#x2013;38.</Citation></Reference><Reference><Citation>Yiu CY, et al. Inhibition of Epstein-Barr virus lytic cycle by an ethyl acetate subfraction separated from Polygonum cuspidatum root and its major component, emodin. Molecules. 2014;19:1258&#x2013;1272. doi: 10.3390/molecules19011258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules19011258</ArticleId><ArticleId IdType="pmc">PMC6271450</ArticleId><ArticleId IdType="pubmed">24448066</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, et al. In vitro and in vivo studies of the inhibitory effects of emodin isolated from Polygonum cuspidatum on Coxsakievirus B(4) Molecules. 2013;18:11842&#x2013;11858. doi: 10.3390/molecules181011842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules181011842</ArticleId><ArticleId IdType="pmc">PMC6269740</ArticleId><ArticleId IdType="pubmed">24071990</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CJ, et al. Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression. PLoS ONE. 2015;10:e0117602. doi: 10.1371/journal.pone.0117602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0117602</ArticleId><ArticleId IdType="pmc">PMC4319845</ArticleId><ArticleId IdType="pubmed">25658356</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JS, et al. Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antiviral Res. 2005;66:29&#x2013;34. doi: 10.1016/j.antiviral.2004.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2004.12.006</ArticleId><ArticleId IdType="pubmed">15781129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HW, et al. Anti-HIV activities of the compounds isolated from Polygonum cuspidatum and Polygonum multiflorum. Planta Med. 2010;76:889&#x2013;892. doi: 10.1055/s-0029-1240796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1240796</ArticleId><ArticleId IdType="pubmed">20112182</ArticleId></ArticleIdList></Reference><Reference><Citation>(LSID), I. L. S. I. International Plants Name Index (IPNI), https://www.ipni.org/n/695612&#x2013;1.</Citation></Reference><Reference><Citation>Ding X-P, et al. The Spectrum-Effect integrated fingerprint of Polygonum cuspidatum based on HPLC-diode array detection-flow injection-chemiluminescence. Chin. J. Nat. Med. 2013;11:546&#x2013;552. doi: 10.3724/SP.J.1009.2013.00546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/SP.J.1009.2013.00546</ArticleId><ArticleId IdType="pubmed">24359782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YC, et al. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Arch. Virol. 2012;157:681&#x2013;688. doi: 10.1007/s00705-012-1224-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1224-z</ArticleId><ArticleId IdType="pubmed">22249364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L-T, et al. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol. 2013;13:187. doi: 10.1186/1471-2180-13-187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-13-187</ArticleId><ArticleId IdType="pmc">PMC3750913</ArticleId><ArticleId IdType="pubmed">23924316</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-H, et al. Highly bioavailable silibinin nanoparticles inhibit HCV infection. Gut. 2017;66:1853&#x2013;1861. doi: 10.1136/gutjnl-2016-312019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-312019</ArticleId><ArticleId IdType="pubmed">27436270</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, et al. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology. 2006;346:53&#x2013;65. doi: 10.1016/j.virol.2005.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.10.030</ArticleId><ArticleId IdType="pubmed">16325883</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana J, et al. Role of capsid anchor in the morphogenesis of Zika virus. J. Virol. 2018;92:01174. doi: 10.1128/JVI.01174-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01174-18</ArticleId><ArticleId IdType="pmc">PMC6206493</ArticleId><ArticleId IdType="pubmed">30158295</ArticleId></ArticleIdList></Reference><Reference><Citation>Weger-Lucarelli J, et al. Development and characterization of recombinant virus generated from a new world Zika virus infectious clone. J. Virol. 2017;91:1765. doi: 10.1128/JVI.01765-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01765-16</ArticleId><ArticleId IdType="pmc">PMC5165210</ArticleId><ArticleId IdType="pubmed">27795432</ArticleId></ArticleIdList></Reference><Reference><Citation>Weger-Lucarelli J, Duggal NK, Brault AC, Geiss BJ, Ebel GD. Rescue and characterization of recombinant virus from a new world Zika virus infectious clone. J. Vis. Exp. 2017 doi: 10.3791/55857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/55857</ArticleId><ArticleId IdType="pmc">PMC5608285</ArticleId><ArticleId IdType="pubmed">28654045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L-T, et al. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J. Virol. 2011;85:4386&#x2013;4398. doi: 10.1128/JVI.01492-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01492-10</ArticleId><ArticleId IdType="pmc">PMC3126266</ArticleId><ArticleId IdType="pubmed">21307190</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, et al. Therapeutic efficacy of antibodies lacking Fcgamma receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected] PLoS Pathog. 2013;9:e1003157. doi: 10.1371/journal.ppat.1003157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003157</ArticleId><ArticleId IdType="pmc">PMC3573116</ArticleId><ArticleId IdType="pubmed">23459315</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 2000;74:7814&#x2013;7823. doi: 10.1128/jvi.74.17.7814-7823.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.17.7814-7823.2000</ArticleId><ArticleId IdType="pmc">PMC112311</ArticleId><ArticleId IdType="pubmed">10933688</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonnak K, et al. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J. Virol. 2008;82:3939&#x2013;3951. doi: 10.1128/JVI.02484-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02484-07</ArticleId><ArticleId IdType="pmc">PMC2292981</ArticleId><ArticleId IdType="pubmed">18272578</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y-Y, et al. Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody. BMC Microbiol. 2013;13:194. doi: 10.1186/1471-2180-13-194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-13-194</ArticleId><ArticleId IdType="pmc">PMC3765915</ArticleId><ArticleId IdType="pubmed">23987307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin LT, et al. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. J. Hepatol. 2015;62:541&#x2013;548. doi: 10.1016/j.jhep.2014.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2014.10.040</ArticleId><ArticleId IdType="pubmed">25450204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong YY, Thay CH, Tin TC, Devi S. Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR. J. Virol. Methods. 2006;138:123&#x2013;130. doi: 10.1016/j.jviromet.2006.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2006.08.003</ArticleId><ArticleId IdType="pubmed">17000012</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wispelaere M, Yang PL. Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly. J. Virol. 2012;86:7072&#x2013;7083. doi: 10.1128/JVI.00224-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00224-12</ArticleId><ArticleId IdType="pmc">PMC3416339</ArticleId><ArticleId IdType="pubmed">22532681</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai CJ, Li CL, Tai CJ, Wang CK, Lin LT. Early viral entry assays for the identification and evaluation of antiviral compounds. J. Vis. Exp. 2015;29:e53124. doi: 10.3791/53124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/53124</ArticleId><ArticleId IdType="pmc">PMC4692676</ArticleId><ArticleId IdType="pubmed">26555014</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Oliveira C, et al. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 2015;39:155&#x2013;170. doi: 10.1093/femsre/fuu004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuu004</ArticleId><ArticleId IdType="pubmed">25725010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S, Pierson TC, Dowd KA. Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection. Methods Mol. Biol. 2014;1138:75&#x2013;97. doi: 10.1007/978-1-4939-0348-1_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-0348-1_6</ArticleId><ArticleId IdType="pubmed">24696332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CF, Tu CH, Lo YP, Cheng CC, Chen WJ. Involvement of tetraspanin C189 in cell-to-cell spreading of the dengue virus in C6/36 cells. PLoS Negl. Trop. Dis. 2015;9:e0003885. doi: 10.1371/journal.pntd.0003885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003885</ArticleId><ArticleId IdType="pmc">PMC4488468</ArticleId><ArticleId IdType="pubmed">26132143</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, et al. Infection of five human liver cell lines by dengue-2 virus. J Med Virol. 2000;60:425&#x2013;431. doi: 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">10686026</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta EG, Castilla V, Damonte EB. Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. J. Gen. Virol. 2008;89:474&#x2013;484. doi: 10.1099/vir.0.83357-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83357-0</ArticleId><ArticleId IdType="pubmed">18198378</ArticleId></ArticleIdList></Reference><Reference><Citation>Koishi AC, Zanello PR, Bianco &#xc9;M, Bordignon J, dos Santos CND. Screening of Dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay. PLoS ONE. 2012;7:e51089. doi: 10.1371/journal.pone.0051089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051089</ArticleId><ArticleId IdType="pmc">PMC3515490</ArticleId><ArticleId IdType="pubmed">23227238</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitby K, et al. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J. Virol. 2005;79:8698&#x2013;8706. doi: 10.1128/JVI.79.14.8698-8706.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.14.8698-8706.2005</ArticleId><ArticleId IdType="pmc">PMC1168722</ArticleId><ArticleId IdType="pubmed">15994763</ArticleId></ArticleIdList></Reference><Reference><Citation>Estoppey D, et al. The natural product cavinafungin selectively interferes with Zika and dengue virus replication by inhibition of the host signal peptidase. Cell Rep. 2017;19:451&#x2013;460. doi: 10.1016/j.celrep.2017.03.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.03.071</ArticleId><ArticleId IdType="pubmed">28423309</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana VM, et al. Antiviral activity of natural and synthetic beta-carbolines against dengue virus. Antiviral Res. 2016;134:26&#x2013;33. doi: 10.1016/j.antiviral.2016.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.08.018</ArticleId><ArticleId IdType="pubmed">27568370</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez-Calvo A, Jimenez de Oya N, Martin-Acebes MA, Garcia-Moruno E, Saiz JC. Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses west Nile virus, Zika virus, and dengue virus. Front. Microbiol. 2017;8:1314. doi: 10.3389/fmicb.2017.01314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01314</ArticleId><ArticleId IdType="pmc">PMC5504193</ArticleId><ArticleId IdType="pubmed">28744282</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood R, et al. Cissampelos pareira Linn: natural source of potent antiviral activity against all four dengue virus serotypes. PLoS Negl. Trop. Dis. 2015;9:e0004255. doi: 10.1371/journal.pntd.0004255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004255</ArticleId><ArticleId IdType="pmc">PMC4692392</ArticleId><ArticleId IdType="pubmed">26709822</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M, et al. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin. Antiviral Res. 2017;143:176&#x2013;185. doi: 10.1016/j.antiviral.2017.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.026</ArticleId><ArticleId IdType="pubmed">28389141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YB, et al. Ecdysones from Zoanthus spp. with inhibitory activity against dengue virus 2. Biorg. Med. Chem. Lett. 2016;26:2344&#x2013;2348. doi: 10.1016/j.bmcl.2016.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2016.03.029</ArticleId><ArticleId IdType="pubmed">26988299</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan HA, Bahrani H, Rahman NA, Yusof R. Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus. BMC Microbiol. 2014;14:140. doi: 10.1186/1471-2180-14-140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-14-140</ArticleId><ArticleId IdType="pmc">PMC4073510</ArticleId><ArticleId IdType="pubmed">24885331</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn DW, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 2000;181:2&#x2013;9. doi: 10.1086/315215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315215</ArticleId><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong V, et al. Asymptomatic humans transmit dengue virus to mosquitoes. Proc. Natl. Acad. Sci. USA. 2015;112:14688&#x2013;14693. doi: 10.1073/pnas.1508114112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508114112</ArticleId><ArticleId IdType="pmc">PMC4664300</ArticleId><ArticleId IdType="pubmed">26553981</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi T, Zhang H, Cai Z. Analysis of Rhizoma Polygoni Cuspidati by HPLC and HPLC-ESI/MS. Phytochem. Anal. 2007;18:387&#x2013;392. doi: 10.1002/pca.993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pca.993</ArticleId><ArticleId IdType="pubmed">17624903</ArticleId></ArticleIdList></Reference><Reference><Citation>Zainal N, et al. Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection. Sci. Rep. 2017;7:42998. doi: 10.1038/srep42998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42998</ArticleId><ArticleId IdType="pmc">PMC5316936</ArticleId><ArticleId IdType="pubmed">28216632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi K, et al. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol. J. 2011;8:560. doi: 10.1186/1743-422X-8-560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-560</ArticleId><ArticleId IdType="pmc">PMC3271998</ArticleId><ArticleId IdType="pubmed">22201648</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison SCJNI. Immunogenic cross-talk between dengue and Zika viruses. Nat. Immunol. 2016;17:1010. doi: 10.1038/ni.3539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3539</ArticleId><ArticleId IdType="pubmed">27540984</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirohi D, et al. The 3.8 &#xc5; resolution cryo-EM structure of Zika virus. Science. 2016;352:467&#x2013;470. doi: 10.1126/science.aaf5316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf5316</ArticleId><ArticleId IdType="pmc">PMC4845755</ArticleId><ArticleId IdType="pubmed">27033547</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira WK, et al. Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis. Lancet. 2017;390:861&#x2013;870. doi: 10.1016/S0140-6736(17)31368-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31368-5</ArticleId><ArticleId IdType="pubmed">28647172</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>